Process measure: patient education materials provideda | Process measure: provider recommended HPV vaccine | Patient outcome: receipt of HPV vaccine dose at initial visit | Patient outcome: completion of 3 doses at 12-month follow up | |||||
---|---|---|---|---|---|---|---|---|
No | Yes | No | Yes | No | Yes | No | Yes | |
Study Arm | Nb (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
Usual Care (UC) Arm | 92 (66.2) | 47 (33.8) | 82 (49.7) | 83 (50.3) | 112 (67.1) | 55 (32.9) | 137 (82.0) | 30 (18.0) |
Intervention Arm | 15 (7.9) | 174 (92.1) | 20 (10.8) | 166 (89.2) | 106 (54.6) | 88 (45.4) | 170 (87.6) | 24 (12.4) |
Crude RRc (95% CI)d | 2.72 (1.97-3.76) | 1.77 (1.44-2.19) | 1.38 (1.03-1.85) | 0.69 (0.40-1.17) | ||||
Adjusted RRe (95% CI)d | 2.88 (2.06-4.01) | 1.70 (1.38-2.10) | 1.18 (0.87-1.60) | 0.50 (0.29-0.88) |